Home Profound

Profound

In operation
Post-IPO Round
Prostate Cancer Treatment Device Developer

Basic Information

The Profound Medical team is committed to creating a powerful combination of real-time MR guidance as an imaging platform and ultrasound as an energy source to provide clinicians with a non-invasive ablation tool. These key technology pillars, combined with intelligent software and robotics, have the potential to address unmet needs for both patients and clinicians across many anatomical and disease states, including prostate cancer, uterine fibroids, and bone metastases.
Profound Medical Corp.
Ontario,Canada
15~50 people
January 01, 2008
info@profoundmedical.com